You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
CarbonWatch: Rock Physics-Based Machine Learning Solution for End-to-End Monitoring of CO2 Storage Site
SBC: Teverra LLC Topic: C5321dC53-21d-271370CCS is a key technology for the mitigation of greenhouse gas emissions. Finding suitable geological storage sites, demonstrating effective CO2 containment, and establishing long-term monitoring of storage reservoirs are paramount to effective and safe storage of CO2. The risk of CO2 leakage can be reduced through real- time monitoring and early prediction of possible leaks. Early pre ...
SBIR Phase II 2023 Department of Energy -
Heat-Sweep Monitoring with Bubbled Water Seismic Imaging
SBC: Teverra LLC Topic: C5621aIn a geothermal reservoir, injected water flows through certain fluid pathways such as natural or induced fractures connecting injection and production wells to harvest the thermal energy from surrounding rocks. The spatial distribution and temporal movement of the fluid in the reservoir is the determining factor of the heat-sweep efficiency. Currently, monitoring of the heat-sweep efficiency is m ...
SBIR Phase I 2023 Department of Energy -
Dechlorination of Mixed-Plastics Feedstock with Low Temperature Pyrolysis for Downstream Gasification and Hydrogen Production
SBC: MICROBEAM TECHNOLOGIES INCORPORATED Topic: C5626dMunicipal Solid Waste (MSW) is a huge untapped renewable feedstock resource to produce hydrogen through gasification. Currently, the utilization MSW for hydrogen production is not realized due to the presence of chlorine that causes degradation of gasifier components and formation of pollutants during gasification. This proposed technology has the potential to remove chlorine and produce a consist ...
SBIR Phase I 2023 Department of Energy -
Next Generation Microlayer Annular Co-Extrusion
SBC: Guill Tool & Engineering Co, Inc. Topic: C5620cAnnular extruded plastics are in everything from fuel lines, hoses, pipes, and wires to catheters, medical tubing, and stents and makes up about ? of the $200B extruded plastics market. Extrusion manufacturing is a major processor of the $600B raw plastics industry, which produces 380 million metric tons of material each year. The production of these materials accounts for 4% of oil consumption an ...
SBIR Phase I 2023 Department of Energy -
Development Of Yeast Strains for Production of Oleochemicals
SBC: SOUTHEASTERN BIOCHEMICALS, INC. Topic: C5520aGlobally, more than 350 million metric tons of plastic polymers are produced annually, and their production is anticipated to quadruple by 2050. As much as three quarters of this material is single use, and only a small proportion is currently recycled. In 2018, 36 million tons of plastic waste were generated in the United States and 24 percent of that waste was recycled or incinerated. The remain ...
STTR Phase I 2023 Department of Energy -
Precision MRI with a Novel Protein Contrast Agent for Early Detection and Staging of Lung Fibrosis
SBC: INLIGHTA BIOSCIENCES L.L.C. Topic: NHLBISummary Lung diseases, such as interstitial lung diseases including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and acute viral infection are major leading causes of death worldwide. The recent increase due to air pollution, tobacco smoking is and use of E-cigarettes has grown rapidly in the US contributing to a sharp increase in chronic lung diseases. IPF is ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters
SBC: NYTRICX INC Topic: NHLBIAbstract Nytricx is developing a new class of Nitric Oxide (NO)-releasing intravascular medical catheters to combat infection and thrombosis associated with indwelling vascular catheters. NO gas is a natural anti-infective and anti-thrombotic human product principally released from blood vessels and immune cells. Nytricx NO-releasing technology to the catheter surfaces via a polymer matrix, mimics ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
SBC: MOONLIGHT THERAPEUTICS, INC. Topic: NIAIDThe following contains proprietary/privileged information that Moonlight Therapeutics requests not be released to persons outside the government, except for purposes of review and evaluation Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within theSkin) patch for the Treatment of Peanut Allergy Food allergies affect 30 million people in the USA and 17 million in ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Expansion and validation of novel mobile app for guiding home modifications for aging in place
SBC: HomesRenewed Ventures LLC Topic: RPROJECT SUMMARY In this Phase II SBIR, HomesRenewed Ventures, LLC (HRV Washington, DC) will build on our previous efforts to expand and validate an interactive mobile application (APP) for guiding home modifications (environmental interventions) critical to Aging in Place (AiP). Home modifications (HM) are associated with falls preventions, improved activities of daily living (ADLs), and emotional ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
High-throughput functional analysis and clinical relevance of all possible variants of a gene
SBC: HELIGENICS, INC. Topic: NHGRIModern pharmaceuticals have greatly improved the quality of life for many patients suffering a variety of illnesses. Unfortunately, among the 17 most commonly prescribed drugs, only 6 are highly effective for most patients, 5 have a modest effect, and 6 show little clinical effect. Worse still, unwanted illness and death from treatment of patients with the incorrect drug or dosage causes over 275, ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health